Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jennifer Lynn Guerriero, Ph.D.

Concepts (248)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Tumor Microenvironment18202439511.100 Why?
Macrophages8202458001.050 Why?
Receptors, Progesterone3202111590.670 Why?
Neovascularization, Pathologic2202126340.650 Why?
Mammary Neoplasms, Experimental120215060.620 Why?
Neoplasms, Experimental3202012310.590 Why?
Breast Neoplasms102024211870.580 Why?
Histone Deacetylase Inhibitors320217780.520 Why?
Antineoplastic Agents, Alkylating220116180.510 Why?
Receptors, Estrogen3202422520.470 Why?
Lymphocytes, Tumor-Infiltrating7202111050.460 Why?
Receptor, erbB-23202326060.450 Why?
Immune Tolerance1202123230.390 Why?
Immunotherapy7202447550.390 Why?
Cell Line, Tumor152024171740.360 Why?
Drug Resistance, Neoplasm7202153420.350 Why?
HMGB1 Protein120111410.330 Why?
Neoplasms72024223900.300 Why?
Glioblastoma1202335250.300 Why?
Apoptosis8202195280.290 Why?
Myeloid Cells220238400.290 Why?
Lymphocyte Activation1201855050.280 Why?
Lung Neoplasms22024135930.260 Why?
Immunity, Innate3201930800.260 Why?
bcl-X Protein220194120.260 Why?
T-Lymphocytes22021102760.230 Why?
Cyclophosphamide1200822270.210 Why?
Antineoplastic Agents42019136990.190 Why?
Quality Control120248360.190 Why?
Phagocytosis2201815300.190 Why?
Transplantation, Isogeneic120212490.190 Why?
Antineoplastic Combined Chemotherapy Protocols62023118860.180 Why?
Ketones120211830.180 Why?
Antibodies, Bispecific120232050.180 Why?
Furans120212020.170 Why?
Professional-Family Relations220215010.170 Why?
Allergy and Immunology120211750.170 Why?
DNA-Directed DNA Polymerase120234810.170 Why?
CD8-Positive T-Lymphocytes4202346510.170 Why?
Animals2020241694080.160 Why?
Death Domain Receptor Signaling Adaptor Proteins12019330.160 Why?
Mammary Glands, Animal120202730.160 Why?
Mice142024820740.160 Why?
Neoplasm Transplantation2202120180.160 Why?
Caregivers2202123080.150 Why?
Health Communication120212160.150 Why?
Pyrimidinones120203860.150 Why?
Monoclonal Gammopathy of Undetermined Significance120201790.150 Why?
Macrophage Activation220205560.150 Why?
Humans4520247688870.150 Why?
Seizures2202130000.150 Why?
Single-Cell Analysis3202425420.140 Why?
Receptors, Immunologic1202414180.140 Why?
Cisplatin2202016610.140 Why?
Oxadiazoles12017940.140 Why?
BRCA1 Protein2202011560.140 Why?
Necrosis3201116210.140 Why?
Urothelium120192760.140 Why?
Parents2202135970.140 Why?
Xenograft Model Antitumor Assays5202036210.130 Why?
Drug Synergism2201717620.130 Why?
Infant, Newborn, Diseases120215870.130 Why?
Apoptosis Regulatory Proteins2201911510.130 Why?
Artifacts1202419420.130 Why?
Neoplasm Metastasis3202149260.130 Why?
Paclitaxel5202317350.120 Why?
Stromal Cells1202013370.120 Why?
Immunologic Factors2202115970.120 Why?
Estrogen Receptor alpha120195810.120 Why?
Mice, Nude3201136310.120 Why?
Neoadjuvant Therapy3202329090.120 Why?
Adaptive Immunity120197330.110 Why?
Hydroxamic Acids120174830.110 Why?
Gene Expression Profiling3202195490.110 Why?
Female2320243974640.110 Why?
Membrane Glycoproteins1202437140.100 Why?
Drug Administration Schedule1202148620.100 Why?
Antigens, CD1202340320.100 Why?
Ovarian Neoplasms2201949190.100 Why?
Carcinoma, Pancreatic Ductal1202317560.100 Why?
Multiple Myeloma3202051950.100 Why?
Neoplasms, Germ Cell and Embryonal120164930.090 Why?
Colorectal Neoplasms2202269820.090 Why?
Benzamides1201713870.090 Why?
Tumor Burden1201719130.090 Why?
Cell Proliferation42021104860.090 Why?
Software1202444800.090 Why?
Class Ia Phosphatidylinositol 3-Kinase12010770.090 Why?
Cell Transformation, Neoplastic1202028480.090 Why?
Pyrazoles1202020290.090 Why?
Molecular Targeted Therapy2201928300.090 Why?
Cell Differentiation22018116840.090 Why?
Cell Line, Transformed120118670.080 Why?
Serpins120112460.080 Why?
Adaptation, Psychological1202026670.080 Why?
Adenovirus E1A Proteins12008810.080 Why?
Evidence-Based Medicine1202137090.080 Why?
Mice, Transgenic1202195640.080 Why?
bcl-2 Homologous Antagonist-Killer Protein12008710.080 Why?
Epithelial Cells1202037010.080 Why?
Peptides2202443530.080 Why?
Proto-Oncogene Proteins c-bcl-21201514080.080 Why?
Colonic Neoplasms1202025430.080 Why?
Fibroblasts2201641780.070 Why?
Genome, Human2202144560.070 Why?
Image Processing, Computer-Assisted1202490810.070 Why?
bcl-2-Associated X Protein120082820.070 Why?
Signal Transduction42024236520.070 Why?
Cytokines2202174530.070 Why?
Random Allocation1201123960.070 Why?
Urinary Bladder Neoplasms1201922500.070 Why?
Genes, ras120086650.060 Why?
Biomedical Research1202134630.060 Why?
Carcinoma, Renal Cell1202132000.060 Why?
DNA-Binding Proteins2202196180.060 Why?
Lung12024100970.060 Why?
Pancreatic Neoplasms1202354430.060 Why?
Clinical Trials as Topic1202180550.060 Why?
Taxoids120086680.060 Why?
Pyrimidines1201730500.060 Why?
HEK293 Cells2201142910.060 Why?
Stress, Psychological1202045420.060 Why?
Kidney Neoplasms1202143000.060 Why?
Genomics4202159280.050 Why?
Physicians1202146070.050 Why?
DNA, Neoplasm1200817480.050 Why?
Gene Expression Regulation, Neoplastic2201986640.050 Why?
Cells, Cultured32020190230.050 Why?
Antigens, Neoplasm1201120010.050 Why?
Gene Expression Regulation12020119340.050 Why?
Autophagy1201013510.050 Why?
Membrane Proteins1201978850.050 Why?
Aging1202087650.050 Why?
Treatment Outcome42021654850.050 Why?
Antibodies, Monoclonal1201892640.050 Why?
Qualitative Research2202131430.040 Why?
Risk Assessment12021243300.040 Why?
Disease Models, Animal22017183660.040 Why?
Nuclear Family120203110.040 Why?
Time Factors12021402660.040 Why?
Nucleotides, Cyclic12019830.040 Why?
Atlases as Topic120202480.040 Why?
DNA Damage1200824720.040 Why?
Carcinoma, Non-Small-Cell Lung1201754340.040 Why?
Prospective Studies52023549500.040 Why?
Genetic Heterogeneity120217370.040 Why?
Prognosis42021300440.040 Why?
Cell Communication1202416600.040 Why?
Object Attachment120203310.040 Why?
Disease Progression42019136770.030 Why?
Risk Factors22022749710.030 Why?
Antibody-Dependent Cell Cytotoxicity120183060.030 Why?
Microsatellite Instability120207260.030 Why?
Burns1200819010.030 Why?
Genes, Tumor Suppressor1202010640.030 Why?
Carboplatin120197990.030 Why?
Antigen Presentation1202112520.030 Why?
Octamer Transcription Factor-3120162210.030 Why?
Male1020213652490.030 Why?
Uncertainty120207690.030 Why?
Cytochromes c120151730.030 Why?
Estrogens1202115370.030 Why?
Loss of Heterozygosity120166630.030 Why?
BRCA2 Protein120198030.030 Why?
Parenting120207090.030 Why?
Health Care Surveys1202124370.030 Why?
Interleukin-101201911840.030 Why?
Teratoma120164050.030 Why?
Middle Aged720232237400.030 Why?
Phenotype22021167350.030 Why?
Aged620231717900.030 Why?
Lymphocytes1202026140.030 Why?
Transcription Factors22023121740.030 Why?
Mitochondria2201636830.030 Why?
Histone Deacetylases120177180.030 Why?
Biological Assay120156280.030 Why?
Mutation32024302660.020 Why?
Sequence Analysis, RNA1202020410.020 Why?
Chemotherapy, Adjuvant1202035540.020 Why?
Leadership1202113960.020 Why?
Plasma Cells120155990.020 Why?
Protein-Tyrosine Kinases1202024330.020 Why?
Fear1202014940.020 Why?
Class III Phosphatidylinositol 3-Kinases12010170.020 Why?
Infant, Newborn22021263940.020 Why?
Organ Specificity1201519700.020 Why?
Testicular Neoplasms120168050.020 Why?
Phosphatidylinositol Phosphates120102010.020 Why?
Antibodies, Neoplasm120112830.020 Why?
Aniline Compounds1201510940.020 Why?
Dendritic Cells1202027480.020 Why?
Phagosomes120101980.020 Why?
Tissue Array Analysis120115510.020 Why?
Cell Cycle Proteins1202034500.020 Why?
Phylogeny1201628430.020 Why?
Adaptor Proteins, Vesicular Transport120103030.020 Why?
Nuclear Proteins1202358030.020 Why?
Patient Care Team1202025270.020 Why?
Killer Cells, Natural1201822110.020 Why?
Proto-Oncogene Proteins p21(ras)1201617690.020 Why?
High-Throughput Nucleotide Sequencing1202036710.020 Why?
Evolution, Molecular1201618940.020 Why?
Biopolymers120081830.020 Why?
Combined Modality Therapy1201985590.020 Why?
Survival Rate12021128730.020 Why?
CD4-Positive T-Lymphocytes1201944130.020 Why?
Survival Analysis12019101150.020 Why?
Early Detection of Cancer1202132380.020 Why?
Tumor Suppressor Protein p531201629600.020 Why?
Adult420212238180.020 Why?
Proportional Hazards Models12020125630.020 Why?
Drug Screening Assays, Antitumor120087190.020 Why?
Sulfonamides1201519820.020 Why?
Immunohistochemistry12019111190.020 Why?
Immunoenzyme Techniques1200817050.020 Why?
Anxiety1202046770.020 Why?
Smoking1202290940.010 Why?
Embryo, Mammalian1201016760.010 Why?
Tubulin120086950.010 Why?
Incidence12022215450.010 Why?
Drug Design1200810460.010 Why?
Point Mutation1200815950.010 Why?
Recurrence1201585120.010 Why?
Structure-Activity Relationship1200830560.010 Why?
Mice, Inbred C57BL12020223810.010 Why?
Recombinant Fusion Proteins1201037440.010 Why?
Proto-Oncogene Proteins c-akt1201024600.010 Why?
Disease-Free Survival1201168560.010 Why?
Follow-Up Studies12022393940.010 Why?
Enzyme Inhibitors1201037240.010 Why?
Transplantation, Heterologous1200823950.010 Why?
Ischemia1200819000.010 Why?
Infant12021365410.010 Why?
Quality of Life12020135100.010 Why?
Child, Preschool12021426840.010 Why?
Heart1201044480.010 Why?
Rats, Sprague-Dawley1200882000.010 Why?
Biopsy1200868050.010 Why?
Neoplasm Staging12011112620.010 Why?
Mice, Knockout12010144850.010 Why?
Liver1201075790.010 Why?
Pilot Projects1200887420.010 Why?
Skin1200845070.010 Why?
Young Adult12020601100.010 Why?
Reproducibility of Results12011202440.010 Why?
United States12020731800.010 Why?
Rats12008238470.010 Why?
Aged, 80 and over12015597380.010 Why?
Guerriero's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (248)
Explore
_
Co-Authors (106)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.